Pharmaceutical industry
Biopharma companies are facing increased scrutiny over high prices, but EQRx is taking a bold approach by pricing its drugs 50% to 70% below competition. Meanwhile, the FDA has fully approved Pfizer's COVID-19 vaccine, and biopharma companies are offering six-figure salaries to attract top talent. Key Takeaways: * EQRx&
Pharmaceutical industry
Markets extended gains on Tuesday as investors reacted positively to the Food and Drug Administration's full approval for the COVID-19 vaccine from Pfizer and BioNTech. Jim Cramer and TheStreet Senior Portfolio Analyst Jeff Marks discussed several stocks on their radar, including Palo Alto Networks, economic-growth stocks, and Boeing.
COVID-19
The US could get COVID-19 under control by early next year if vaccination efforts increase, Dr. Anthony Fauci stated on Tuesday. This comes after Pfizer secured fuller FDA approval for its vaccine, with potential approvals for Moderna and Johnson & Johnson's vaccines on the horizon. Fauci emphasized that
COVID-19
The Food and Drug Administration's (FDA) grant of full approval to Pfizer's COVID-19 vaccine is expected to boost vaccination rates and potentially lead to increased foot traffic at movie theater chains. The approval, which covers individuals aged 16 and older, may give more people confidence to
COVID-19 vaccines
As India begins its nationwide mass inoculation drive against COVID-19, the country's vaccine approval process has come under scrutiny. The Drug Controller General of India (DCGI) has approved two vaccines for restricted emergency use: Serum Institute of India's Covishield and Bharat Biotech's Covaxin. However,
COVID-19 vaccines
The Indian government has granted final approval to Covishield and Covaxin, two COVID-19 vaccines manufactured by Serum Institute of India and Bharat Biotech Ltd, respectively, for "emergency use" against the coronavirus. The Drugs Controller General of India (DCGI) formally announced the approval, which follows a recommendation by the
Pfizer Inc.
The United States has added a second COVID-19 vaccine to its arsenal, with the Food and Drug Administration authorizing an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health. This move marks the world's first authorization for Moderna's shots and
COVID-19 vaccines
Investors cheered news of progress toward a fresh stimulus package on Thursday, sending stock futures higher as the market opened. Several stocks made notable moves, driven by a combination of positive earnings reports, mergers and acquisitions, and analyst upgrades. Here is a summary of the top movers in premarket trading
COVID-19 vaccines
New Jersey has started administering the Pfizer COVID-19 vaccine to frontline healthcare workers, with Maritza Beniquez, a 56-year-old emergency room nurse, becoming the first New Jerseyan to receive the vaccine. The vaccine, developed by Pfizer through a partnership with BioNTech, requires two shots and is expected to vaccinate 38,000
Pfizer Inc.
California's divergent governmental responses are exemplified in the Southern California oceanside city of Manhattan Beach, where residents are encouraged to shop and engage in outdoor activities while the state is under a broad shutdown order to slow record-breaking coronavirus cases. Mayor Suzanne Hadley stated that the city'
COVID-19 vaccines
The recent FDA review of Pfizer's coronavirus vaccine found insufficient data to conclude whether the vaccine is safe for children under 16, pregnant women, and immunocompromised individuals. The review also questions the safety of vaccinating individuals who previously got COVID-19, particularly if they have lingering symptoms. Experts worry
Pfizer Inc.
The European Medicines Agency has fallen victim to a cyber attack, resulting in the theft of COVID-19 vaccine data. The agency, responsible for authorizing vaccine use across Europe, has access to trial and safety data from pharmaceutical companies Pfizer and Moderna. Pfizer, whose vaccine is in use in the UK,
